These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 11751969)

  • 1. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF; Whittington KB; Zaller DM; Kang AH
    J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK
    Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q; Cheng YJ; Li ZG; Zhou WH; Lu HS
    Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(17):1505-9. PubMed ID: 14521731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
    J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
    Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
    Rosloniec EF; Ivey RA; Whittington KB; Kang AH; Park HW
    J Immunol; 2006 Sep; 177(6):3884-92. PubMed ID: 16951351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
    Rosloniec EF; Brand DD; Myers LK; Whittington KB; Gumanovskaya M; Zaller DM; Woods A; Altmann DM; Stuart JM; Kang AH
    J Exp Med; 1997 Mar; 185(6):1113-22. PubMed ID: 9091584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
    Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell immunity to type II collagen in the biobreeding rat: the identification and characterization of RT1u-restricted T cell epitopes on alpha 1(II).
    Cremer MA; Ye XJ; Myers LK; Brand DD; Rosloniec EF; Kang AH
    J Immunol; 2004 Aug; 173(3):1795-801. PubMed ID: 15265910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
    Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL
    Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
    Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.
    Hennecke J; Wiley DC
    J Exp Med; 2002 Mar; 195(5):571-81. PubMed ID: 11877480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effects on HLA-DR1-specific T-cell activation by influenza virus haemagglutinin-derived peptides.
    Li X; Li R; Li Z
    Tissue Antigens; 2006 Jan; 67(1):45-52. PubMed ID: 16451200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of T-cell activation with HLA-DR1/DR4 restricted Non-T-cell stimulating peptides.
    Zhou Q; Cheng Y; Lü H; Zhou W; Li Z
    Hum Immunol; 2003 Sep; 64(9):857-65. PubMed ID: 12941540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Analysis of the Peptide Repertoires of HLA-DR Molecules Differentially Associated With Rheumatoid Arthritis.
    Scholz E; Mestre-Ferrer A; Daura X; García-Medel N; Carrascal M; James EA; Kwok WW; Canals F; Álvarez I
    Arthritis Rheumatol; 2016 Oct; 68(10):2412-21. PubMed ID: 27158783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of altered collagen II peptide on HLA-DRB1-restricted T-cell activation.
    Cheng YJ; Zhou Q; Li ZG
    Scand J Immunol; 2005 Mar; 61(3):260-5. PubMed ID: 15787743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell epitopes of human myelin oligodendrocyte glycoprotein identified in HLA-DR4 (DRB1*0401) transgenic mice are encephalitogenic and are presented by human B cells.
    Forsthuber TG; Shive CL; Wienhold W; de Graaf K; Spack EG; Sublett R; Melms A; Kort J; Racke MK; Weissert R
    J Immunol; 2001 Dec; 167(12):7119-25. PubMed ID: 11739534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRbeta1*0401 transgenic mouse model.
    Hill JA; Wang D; Jevnikar AM; Cairns E; Bell DA
    Arthritis Res Ther; 2003; 5(1):R40-8. PubMed ID: 12716452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.